Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain

Although bone cancer pain is still not fully understood by scientists and clinicians alike, studies suggest that toll like receptor 4 (TLR4) plays an important role in the initiation and/or maintenance of pathological pain state in bone cancer pain. A promising treatment for bone cancer pain is the...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruirui Pan, Huiting Di, Jinming Zhang, Zhangxiang Huang, Yuming Sun, Weifeng Yu, Feixiang Wu
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2015/523896
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554692550328320
author Ruirui Pan
Huiting Di
Jinming Zhang
Zhangxiang Huang
Yuming Sun
Weifeng Yu
Feixiang Wu
author_facet Ruirui Pan
Huiting Di
Jinming Zhang
Zhangxiang Huang
Yuming Sun
Weifeng Yu
Feixiang Wu
author_sort Ruirui Pan
collection DOAJ
description Although bone cancer pain is still not fully understood by scientists and clinicians alike, studies suggest that toll like receptor 4 (TLR4) plays an important role in the initiation and/or maintenance of pathological pain state in bone cancer pain. A promising treatment for bone cancer pain is the downregulation of TLR4 by RNA interference; however, naked siRNA (small interference RNA) is not effective in long-term treatments. In order to concoct a viable prolonged treatment for bone cancer pain, an inducible lentivirus LvOn-siTLR4 (tetracycline inducible lentivirus carrying siRNA targeting TLR4) was prepared and the antinociception effects were observed in bone cancer pain rats induced by Walker 256 cells injection in left leg. Results showed that LvOn-siTLR4 intrathecal injection with doxycycline (Dox) oral administration effectively reduced the nociception induced by Walker 256 cells while inhibiting the mRNA and protein expression of TLR4. Proinflammatory cytokines as TNF-α and IL-1β in spinal cord were also decreased. These findings suggest that TLR4 could be a target for bone cancer pain treatment and tetracycline inducible lentivirus LvOn-siTLR4 represents a new potential option for long-term treatment of bone cancer pain.
format Article
id doaj-art-28de1847c47c444fae32dc865fcb7729
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-28de1847c47c444fae32dc865fcb77292025-02-03T05:50:46ZengWileyMediators of Inflammation0962-93511466-18612015-01-01201510.1155/2015/523896523896Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer PainRuirui Pan0Huiting Di1Jinming Zhang2Zhangxiang Huang3Yuming Sun4Weifeng Yu5Feixiang Wu6Department of Anesthesiology, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai 200438, ChinaDepartment of Anesthesiology, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai 200438, ChinaDepartment of Anesthesiology, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai 200438, ChinaDepartment of Anesthesiology, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai 200438, ChinaDepartment of Anesthesiology, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai 200438, ChinaDepartment of Anesthesiology, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai 200438, ChinaDepartment of Anesthesiology, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai 200438, ChinaAlthough bone cancer pain is still not fully understood by scientists and clinicians alike, studies suggest that toll like receptor 4 (TLR4) plays an important role in the initiation and/or maintenance of pathological pain state in bone cancer pain. A promising treatment for bone cancer pain is the downregulation of TLR4 by RNA interference; however, naked siRNA (small interference RNA) is not effective in long-term treatments. In order to concoct a viable prolonged treatment for bone cancer pain, an inducible lentivirus LvOn-siTLR4 (tetracycline inducible lentivirus carrying siRNA targeting TLR4) was prepared and the antinociception effects were observed in bone cancer pain rats induced by Walker 256 cells injection in left leg. Results showed that LvOn-siTLR4 intrathecal injection with doxycycline (Dox) oral administration effectively reduced the nociception induced by Walker 256 cells while inhibiting the mRNA and protein expression of TLR4. Proinflammatory cytokines as TNF-α and IL-1β in spinal cord were also decreased. These findings suggest that TLR4 could be a target for bone cancer pain treatment and tetracycline inducible lentivirus LvOn-siTLR4 represents a new potential option for long-term treatment of bone cancer pain.http://dx.doi.org/10.1155/2015/523896
spellingShingle Ruirui Pan
Huiting Di
Jinming Zhang
Zhangxiang Huang
Yuming Sun
Weifeng Yu
Feixiang Wu
Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain
Mediators of Inflammation
title Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain
title_full Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain
title_fullStr Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain
title_full_unstemmed Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain
title_short Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain
title_sort inducible lentivirus mediated sirna against tlr4 reduces nociception in a rat model of bone cancer pain
url http://dx.doi.org/10.1155/2015/523896
work_keys_str_mv AT ruiruipan induciblelentivirusmediatedsirnaagainsttlr4reducesnociceptioninaratmodelofbonecancerpain
AT huitingdi induciblelentivirusmediatedsirnaagainsttlr4reducesnociceptioninaratmodelofbonecancerpain
AT jinmingzhang induciblelentivirusmediatedsirnaagainsttlr4reducesnociceptioninaratmodelofbonecancerpain
AT zhangxianghuang induciblelentivirusmediatedsirnaagainsttlr4reducesnociceptioninaratmodelofbonecancerpain
AT yumingsun induciblelentivirusmediatedsirnaagainsttlr4reducesnociceptioninaratmodelofbonecancerpain
AT weifengyu induciblelentivirusmediatedsirnaagainsttlr4reducesnociceptioninaratmodelofbonecancerpain
AT feixiangwu induciblelentivirusmediatedsirnaagainsttlr4reducesnociceptioninaratmodelofbonecancerpain